Clinical Trial Results

Showing: All studies [change]
Condition: Breast Cancer Location: Minnesota 25 trials found
New Search
Filter
Trial Phase
Study Type
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
PHASE1, PHASE2INTERVENTIONAL Gilbert, Arizona +4 more
RECRUITING
Primary Breast Oligoprogressive Sites Treated With Radiotherapy to Obviate the Need to Change Systemic Therapy
NAINTERVENTIONAL Scottsdale, Arizona +1 more
RECRUITING
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
PHASE3INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
Collection of Specimens and Clinical Data for Patients With Recurrent or Metastatic Breast Cancer or Male Breast Cancer
N/AOBSERVATIONAL Rochester, Minnesota
RECRUITING
MUSE-S Headband System for Improving Anxiety and Insomnia Among Breast Cancer Survivors
EARLY_PHASE1INTERVENTIONAL Rochester, Minnesota
RECRUITING
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis
PHASE1, PHASE2INTERVENTIONAL Westwood, Kansas +2 more
RECRUITING
Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer
PHASE3INTERVENTIONAL Gilbert, Arizona +4 more
RECRUITING
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
PHASE1, PHASE2INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer
PHASE3INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
PHASE3INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BTX-9341 in Advanced and/or Metastatic Breast Cancer
PHASE1INTERVENTIONAL Rochester, Minnesota +4 more
RECRUITING
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
PHASE1INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer
PHASE1INTERVENTIONAL Springdale, Arkansas +4 more
RECRUITING
First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
PHASE1, PHASE2INTERVENTIONAL New Haven, Connecticut +4 more
RECRUITING
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
PHASE1, PHASE2INTERVENTIONAL Gilbert, Arizona +4 more
RECRUITING
Collecting Patient-Reported Experiences With Radiation Dermatitis in Breast Cancer Patients Undergoing Radiotherapy
N/AOBSERVATIONAL Rochester, Minnesota
RECRUITING
Multi-Cancer Detection Observational Cohort Study
N/AOBSERVATIONAL Scottsdale, Arizona +2 more
RECRUITING
An Optimized Ultrasound Twinkling Marker for the Imaging of Lymph Nodes in Patients With Clinically Node-Positive Breast Cancer, The UTMOST2 Trial
PHASE1INTERVENTIONAL Rochester, Minnesota
RECRUITING
A 3D-Printed External Breast Prosthesis for the Improvement of Patient-reported Outcomes Among Breast Cancer Patients That Underwent a Mastectomy Without Reconstruction
NAINTERVENTIONAL Rochester, Minnesota
RECRUITING
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
PHASE1, PHASE2INTERVENTIONAL Orlando, Florida +4 more
RECRUITING
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
PHASE3INTERVENTIONAL Anchorage, Alaska +4 more
RECRUITING
Integrating Molecular Pathology, Radiology, and Genetics to Improve Breast Cancer Risk
N/AOBSERVATIONAL Jacksonville, Florida +1 more
RECRUITING
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
NAINTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Filter Trials
Trial Phase
Study Type